A+ Science Invest AB
Records under this name other than patents A+ Science Invest AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,427,589 | Use of cytokine inhibitors Formerly held Term ended Term ended Jun 3, 2022 · USPTO record | Term ended | Term ended Jun 3, 2022 | USPTO record |
| US 7,253,143 | Peptides based on the sequence of human lactoferrin and their use Formerly held Term ended Term ended Jul 6, 2019 · USPTO record | Term ended | Term ended Jul 6, 2019 | USPTO record |
| US 6,388,746 | Method, apparatus and flow cell for high-sensitivity detection of fluorescent molecules Formerly held Term ended Term ended Feb 5, 2019 · USPTO record | Term ended | Term ended Feb 5, 2019 | USPTO record |
| US 6,171,819 | Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function Formerly held Term ended Term ended Dec 2, 2018 · USPTO record | Term ended | Term ended Dec 2, 2018 | USPTO record |
| US 6,521,430 | Method for electro-permeabilization of individual cellular and organellar structures and use thereof Formerly held Term ended Term ended Nov 6, 2018 · USPTO record | Term ended | Term ended Nov 6, 2018 | USPTO record |
| US 6,034,117 | Methods of treating and diagnosing sleep disordered breathing and means for carrying out the method Formerly held Term ended Term ended Sep 21, 2018 · USPTO record | Term ended | Term ended Sep 21, 2018 | USPTO record |
| US 6,455,303 | Detection of biologically active molecules by use of pre-activated cell-based biosensors in liquid-based separation systems Formerly held Term ended Term ended Jun 3, 2018 · USPTO record | Term ended | Term ended Jun 3, 2018 | USPTO record |
| US 6,797,264 | Medicinal Product and Method for Treatment of Conditions Affecting Neural Stem Cells or Progenitor Cells Formerly held Lapsed on the fee record Ended Sep 28, 2016 · High confidence | Lapsed on the fee record | Ended Sep 28, 2016 | High confidence |
| US 6,649,589 | Use of certain drugs for treating nerve root injury Formerly held Lapsed on the fee record Ended Nov 18, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 18, 2015 | USPTO record |
| US 6,635,250 | Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus Formerly held Lapsed on the fee record Ended Oct 21, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2015 | USPTO record |